BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20824083)

  • 1. Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest.
    Belzile JP; Abrahamyan LG; Gérard FC; Rougeau N; Cohen EA
    PLoS Pathog; 2010 Sep; 6(9):e1001080. PubMed ID: 20824083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest.
    Belzile JP; Richard J; Rougeau N; Xiao Y; Cohen EA
    J Virol; 2010 Apr; 84(7):3320-30. PubMed ID: 20089662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.
    Belzile JP; Duisit G; Rougeau N; Mercier J; Finzi A; Cohen EA
    PLoS Pathog; 2007 Jul; 3(7):e85. PubMed ID: 17630831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.
    Romani B; Shaykh Baygloo N; Aghasadeghi MR; Allahbakhshi E
    J Biol Chem; 2015 Jul; 290(28):17380-9. PubMed ID: 26032416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the interactions and role of DCAF1/VPRBP in the DDB1-cullin4A E3 ubiquitin ligase complex engaged by HIV-1 Vpr to induce a G2 cell cycle arrest.
    Gérard FC; Yang R; Romani B; Poisson A; Belzile JP; Rougeau N; Cohen ÉA
    PLoS One; 2014; 9(2):e89195. PubMed ID: 24558487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest.
    Hakata Y; Miyazawa M; Landau NR
    Virol J; 2014 Jun; 11():108. PubMed ID: 24912982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development.
    McCall CM; Miliani de Marval PL; Chastain PD; Jackson SC; He YJ; Kotake Y; Cook JG; Xiong Y
    Mol Cell Biol; 2008 Sep; 28(18):5621-33. PubMed ID: 18606781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle.
    Hrecka K; Gierszewska M; Srivastava S; Kozaczkiewicz L; Swanson SK; Florens L; Washburn MP; Skowronski J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11778-83. PubMed ID: 17609381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.
    Pham TN; Richard J; Gerard FC; Power C; Cohen ÉA
    J Virol; 2011 Dec; 85(23):12254-61. PubMed ID: 21957298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.
    Wang H; Guo H; Su J; Rui Y; Zheng W; Gao W; Zhang W; Li Z; Liu G; Markham RB; Wei W; Yu XF
    J Virol; 2017 May; 91(9):. PubMed ID: 28202763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation.
    Zimmerman ES; Chen J; Andersen JL; Ardon O; Dehart JL; Blackett J; Choudhary SK; Camerini D; Nghiem P; Planelles V
    Mol Cell Biol; 2004 Nov; 24(21):9286-94. PubMed ID: 15485898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest.
    Tan L; Ehrlich E; Yu XF
    J Virol; 2007 Oct; 81(19):10822-30. PubMed ID: 17626091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo.
    Lai M; Zimmerman ES; Planelles V; Chen J
    J Virol; 2005 Dec; 79(24):15443-51. PubMed ID: 16306615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.
    Wang X; Singh S; Jung HY; Yang G; Jun S; Sastry KJ; Park JI
    J Biol Chem; 2013 May; 288(22):15474-80. PubMed ID: 23612978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Vpr hijacks EDD-DYRK2-DDB1
    Hossain D; Ferreira Barbosa JA; Cohen ÉA; Tsang WY
    J Biol Chem; 2018 Jun; 293(24):9448-9460. PubMed ID: 29724823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly with the Cul4A-DDB1DCAF1 ubiquitin ligase protects HIV-1 Vpr from proteasomal degradation.
    Le Rouzic E; Morel M; Ayinde D; Belaïdouni N; Letienne J; Transy C; Margottin-Goguet F
    J Biol Chem; 2008 Aug; 283(31):21686-92. PubMed ID: 18524771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Vpr induces the degradation of ZIP and sZIP, adaptors of the NuRD chromatin remodeling complex, by hijacking DCAF1/VprBP.
    Maudet C; Sourisce A; Dragin L; Lahouassa H; Rain JC; Bouaziz S; Ramirez BC; Margottin-Goguet F
    PLoS One; 2013; 8(10):e77320. PubMed ID: 24116224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.
    Ahn J; Vu T; Novince Z; Guerrero-Santoro J; Rapic-Otrin V; Gronenborn AM
    J Biol Chem; 2010 Nov; 285(48):37333-41. PubMed ID: 20870715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.
    DeHart JL; Zimmerman ES; Ardon O; Monteiro-Filho CM; Argañaraz ER; Planelles V
    Virol J; 2007 Jun; 4():57. PubMed ID: 17559673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Vpr in HIV-1 disease progression is independent of its G2 arrest induction function.
    Lai M; Chen J
    Cell Cycle; 2006 Oct; 5(19):2275-80. PubMed ID: 16969134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.